ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,045.26
0.38%
US Tech 100
21,346.40
0.00%
Dow Jones
42,967.62
0.24%
Brent Oil
72.845
4.21%
Bitcoin
105,315.22
-0.58%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sonnet BioTherapeutics Holdings Inc (SONN) Quote

Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

NASDAQ
1.18
0.00
(0.00%)
Closed June 13 4:00PM
15 min delayed - Upgrade to Realtime
0.00
0.00
(0.00%)
After Hours: -
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.18
Bid
1.18
Ask
1.23
Volume
-
0.00 Day's Range 0.00
1.08 52 Week Range 14.80
Market Cap
3.736M
Previous Close
1.18
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
40,868
Shares Outstanding
3,165,810
Dividend Yield
-
PE Ratio
-0.50
Earnings Per Share (EPS)
-2.35
Revenue
19k
Net Profit
-7.44M

About Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector
Pharmaceutical Preparations
Industry
Management Consulting Svcs
Website
www.sonnetbio.com
Headquarters
Wilmington, Delaware, USA
Founded
2020
Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was $1.18. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of $ 1.08 to $ 14.80.

Sonnet BioTherapeutics currently has 3,165,810 shares outstanding. The market capitalization of Sonnet BioTherapeutics is $3.74 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.50.

Ask ADVFN Intelligence (AI)

SONN Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 02 2025
SONN (0.00%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 13 2025
SONN (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
April 04 2025
SONN (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
April 01 2025
SONN (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
March 26 2025
SONN (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.021.724137931031.161.29991.1305495231.22264275CS
4-0.05-4.065040650411.231.37851.08408281.19907925CS
12-0.21-15.10791366911.391.71.08408681.28017066CS
26-0.695-37.06666666671.8752.521.081030411.61117353CS
52-12.98-91.666666666714.1614.81.084076272.85024185CS
156-571.2072-99.7938458442572.3872788.481.081247178248.10220636CS
260-9090.98-99.98702178589092.1619440.961.0821668602266.1861392CS

SONN - Frequently Asked Questions (FAQ)

What is the current Sonnet BioTherapeutics share price?
The current share price of Sonnet BioTherapeutics is $ 1.18
How many Sonnet BioTherapeutics shares are in issue?
Sonnet BioTherapeutics has 3,165,810 shares in issue
What is the market cap of Sonnet BioTherapeutics?
The market capitalisation of Sonnet BioTherapeutics is USD 3.74M
What is the 1 year trading range for Sonnet BioTherapeutics share price?
Sonnet BioTherapeutics has traded in the range of $ 1.08 to $ 14.80 during the past year
What is the PE ratio of Sonnet BioTherapeutics?
The price to earnings ratio of Sonnet BioTherapeutics is -0.5
What is the cash to sales ratio of Sonnet BioTherapeutics?
The cash to sales ratio of Sonnet BioTherapeutics is 196.67
What is the reporting currency for Sonnet BioTherapeutics?
Sonnet BioTherapeutics reports financial results in USD
What is the latest annual turnover for Sonnet BioTherapeutics?
The latest annual turnover of Sonnet BioTherapeutics is USD 19k
What is the latest annual profit for Sonnet BioTherapeutics?
The latest annual profit of Sonnet BioTherapeutics is USD -7.44M
What is the registered address of Sonnet BioTherapeutics?
The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Sonnet BioTherapeutics website address?
The website address for Sonnet BioTherapeutics is www.sonnetbio.com
Which industry sector does Sonnet BioTherapeutics operate in?
Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.10
(0.00%)
0
AACGATA Creativity Global
$ 0.8231
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.36
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.13
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.10
(0.00%)
0
AACGATA Creativity Global
$ 0.8231
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.36
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.13
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.10
(0.00%)
0
AACGATA Creativity Global
$ 0.8231
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.36
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.13
(0.00%)
0

SONN Discussion

View Posts
Monksdream Monksdream 2 months ago
SONN under $2
👍️0
tw0122 tw0122 6 months ago
Cash out time 5.45 + 150%
👍 1
LowFloatLopes LowFloatLopes 6 months ago
I'm at $2.50 out at $4.50 in less than 8 mins lol 
👍️0
tw0122 tw0122 6 months ago
Don't stay in long this one hardly ever stays up high long 3.49 +'80%
👍️0
Monksdream Monksdream 6 months ago
SONN, 10Q due DEC 13
👍️0
tw0122 tw0122 7 months ago
Reverse split was September 
👍️0
Invest-in-America Invest-in-America 7 months ago
SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
👍️0
Tiger Money Tiger Money 7 months ago
What is going on here?  Reverse?  Where is the float on this train wreck now?
👍️0
bigfart bigfart 7 months ago
So insiders can dump before the RS
👍️0
tw0122 tw0122 7 months ago
Reverse split offering and now some news $8s
👍️0
tw0122 tw0122 8 months ago
May the reverse split gods come soon. Keep an eye!
👍️0
BooDog BooDog 9 months ago
Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
👍️0
Clemdane Clemdane 9 months ago
Big jump today!
👍️0
Awl416 Awl416 10 months ago
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
👍️ 1
Monksdream Monksdream 10 months ago
SONN new 52=low
👍️0
Clemdane Clemdane 10 months ago
Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
👍️0
Monksdream Monksdream 10 months ago
SONN new 52 week low
👍️0
Monksdream Monksdream 10 months ago
SONN new 52 week low
👍️0
Monksdream Monksdream 12 months ago
SONN new 52 week low
👍️0
Monksdream Monksdream 12 months ago
SONN new 52 week low
👍️0
BooDog BooDog 1 year ago
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
👍️0
maq1214 maq1214 1 year ago
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
👍️0
81vette 81vette 1 year ago
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
👍️0
81vette 81vette 1 year ago
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
👍️0
maq1214 maq1214 1 year ago
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
👍️0
81vette 81vette 1 year ago
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
👍️0
81vette 81vette 1 year ago
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
👍️0
81vette 81vette 1 year ago
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
👍️0
BooDog BooDog 1 year ago
Riding free again.
👍️0
Monksdream Monksdream 1 year ago
SONN under $2
👍️0
crowin crowin 1 year ago
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
👍️0
maq1214 maq1214 1 year ago
This should get exciting soon, crazy volume yesterday !
👍️0
BooDog BooDog 1 year ago
IS it just greed or might this make good for another round trip? We'll see next week.
👍️0
BooDog BooDog 1 year ago
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
👍️0
Monksdream Monksdream 2 years ago
SONN new 52 week low
👍️0
BooDog BooDog 2 years ago
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
👍️0
valleybenedetto valleybenedetto 2 years ago
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
👍️0
Monksdream Monksdream 2 years ago
SONN new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SONN new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SONN new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SONN new 52 week low
👍️0
valleybenedetto valleybenedetto 2 years ago
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
👍️0
Monksdream Monksdream 2 years ago
If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
👍️0
valleybenedetto valleybenedetto 2 years ago
You worry about you ok?
👍️0
Monksdream Monksdream 2 years ago
You aren’t getting any money back
Time to move on
👍️0
valleybenedetto valleybenedetto 2 years ago
Not an Urban Myth ..I've already checked. They have current D and O insurance.
👍️0
Monksdream Monksdream 2 years ago
Oh goddamn tell me another urban myth
👍️0
valleybenedetto valleybenedetto 2 years ago
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
👍️0
Monksdream Monksdream 2 years ago
You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
👍️0
valleybenedetto valleybenedetto 2 years ago
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
👍️0

Your Recent History

NASDAQ
SONN
Sonnet BioTherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads